Aveo Capital Partners’s Thermo Fisher Scientific TMO Stock Holding History

Aveo Capital Partners’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-655	Closed	-$267K	–	139
2025 Q1	$267K	Sell	655 -576	-47%	-$312K	0.04%	152
2024 Q4	$640K	Buy	1,231 +308	+33%	+$169K	0.07%	174
2024 Q3	$571K	Buy	923 +20	+2%	+$11.8K	0.06%	185
2024 Q2	$499K	Sell	903 -59	-6%	-$33.8K	0.06%	190
2024 Q1	$551K	Buy	962 +146	+18%	+$81.9K	0.06%	202
2023 Q4	$433K	Buy	816 +72	+10%	+$34.9K	0.05%	222
2023 Q3	$377K	Buy	744 +30	+4%	+$16K	0.05%	233
2023 Q2	$373K	Buy	714 +24	+3%	+$13K	0.05%	247
2023 Q1	$398K	Buy	690 +75	+12%	+$42.3K	0.05%	220
2022 Q4	$339K	Buy	615 +154	+33%	+$81.6K	0.05%	247
2022 Q3	$234K	Sell	461 -31	-6%	-$17.3K	0.04%	245
2022 Q2	$267K	Buy	492 +43	+10%	+$23.7K	0.04%	233
2022 Q1	$265K	Sell	449 -7	-2%	-$4.02K	0.05%	234
2021 Q4	$304K	Sell	456 -19	-4%	-$11.9K	0.05%	221
2021 Q3	$271K	Buy	475 +41	+9%	+$22.5K	0.06%	215
2021 Q2	$219K	Buy	+434	New	+$205K	0.05%	246

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Aveo Capital Partners's TMO Position: Q2 2025 in Review

Aveo Capital Partners sold out of Thermo Fisher Scientific (TMO) in Q2 2025, closing a stake of 655 shares — an estimated $267K sold.

Aveo Capital Partners first reported a position in TMO in Q2 2021 and held it in 16 quarters. The position peaked at $640K in Q4 2024. 2,454 funds tracked by Wall St. Rank hold TMO as of Q2 2025.

Aveo Capital Partners reported no remaining Thermo Fisher Scientific position as of Q2 2025 after selling out during the quarter.
Aveo Capital Partners sold 655 Thermo Fisher Scientific shares in Q2 2025, an estimated $267K.
Aveo Capital Partners first reported a position in Thermo Fisher Scientific in Q2 2021 and held it in 16 quarters.
Aveo Capital Partners's Thermo Fisher Scientific position peaked at $640K in Q4 2024.
2,454 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2025.

Based on Aveo Capital Partners's 13F filing for Q2 2025.